References
- Vignes S, Bellanger J. Primary intestinal lymphangiectasia (Waldmann's disease). Orphanet J Rare Dis 2008; 3: 5
- Bode L, Salvestrini C, Park PW, Li JP, Esko JD, Yamaguchi Y, et al. Heparan sulfate and syndecan-1 are essential in maintaining murine and human intestinal epithelial barrier function. J Clin Invest 2008; 118: 229–38
- Rychik J. Protein-losing enteropathy after Fontan operation. Congenit Heart Dis 2007; 2: 288–300
- de Kaski MC, Peters AM, Bradley D, Hodgson HJ. Detection and quantification of protein-losing enteropathy with indium-111 transferrin. Eur J Nucl Med 1996; 23: 530–3
- Macedo MF, de Sousa M. Transferrin and the transferrin receptor: of magic bullets and other concerns. Inflamm Allergy Drug Targets 2008; 7: 41–52
- Thorstensen K, Romslo I. The role of transferrin in the mechanism of cellular iron uptake. Biochem J 1990; 271: 1–9
- Ahlquist DA, Schwartz S, Isaacson J, Ellefson M. A stool collection device: the first step in occult blood testing. Ann Intern Med 1988; 108: 609–12
- Aburano T, Yokoyama K, Kinuya S, Takayama T, Tonami N, Hisada K, et al. Indium-111 transferrin imaging for the diagnosis of protein-losing enteropathy. Clin Nucl Med 1989; 14: 681–5
- Chiu NT, Lee BF, Hwang SJ, Chang JM, Liu GC, Yu HS. Protein-losing enteropathy: diagnosis with (99m)Tc-labeled human serum albumin scintigraphy. Radiology 2001; 219: 86–90
- Kiratli PO, Erbas B, Ozen H, Kocak N. Tc-99m dextran scintigraphy in the diagnosis of protein losing enteropathy. Ann Nucl Med 2001; 15: 153–5
- Seok JW, Kim S, Lee SH, Kim IJ, Kim YK. Protein-losing enteropathy detected on Tc-99m HSA and Tc-99m MDP scintigraphy. Clin Nucl Med 2002; 27: 431–3
- Saverymuttu SH, Peters AM, Lavender JP, Hodgson HJ. Detection of protein-losing enteropathy by 111In-Transferrin scanning. Eur J Nucl Med 1983; 8: 40–1
- Carpani de KM, Peters AM, Knight D, Stuttle AW, Lavender JP, Hodgson HJ. Indium-111 whole-body retention: a method for quantification of disease activity in inflammatory bowel disease. J Nucl Med 1992; 33: 756–62
- Rootwelt K. Direct intravenous injection of 51-chromic chloride compared with 125-I-polyvinylpyrrolidone and 131-I-albumin in the detection of gastrointestinal protein loss. Scand J Clin Lab Invest 1966; 18: 405–16
- Walker-Smith JA, Skyring AP, Mistilis SP. Use of 51-CrCl-3 in the diagnosis of protein-losing enteropathy. Gut 1967; 8: 166–8
- van Tongeren JH, Majoor CL. Demonstration of protein-losing gastroenteropathy. The disappearance rate of 51Cr from plasma and the binding of 51Cr to different serum proteins. Clin Chim Acta 1966; 14: 31–41
- Waldmann TA. Protein-losing enteropathy and kinetic studies of plasma protein metabolism. Semin Nucl Med 1972; 2: 251–63
- Huebers HA, Finch CA. The physiology of transferrin and transferrin receptors. Physiol Rev 1987; 67: 520–82
- Putnam FW. Transferrin. The plasma proteins. Structure, function, and genetic control, FW Putnam. Academic Press, London 1975; 265–311
- Goodwin DA, Goode R, Brown L, Imbornone CJ. 111 In-labeled transferrin for the detection of tumors. Radiology 1971; 100: 175–9
- Berry CR, Fisher P, Koblik PD, Guilford WG, Hornof WH. Scintigraphic biodistribution and plasma kinetics of indium 111-labeled transferrin in dogs. Am J Vet Res 1997; 58: 1188–92
- Rossing N. Intra- and extravascular distribution of albumin and immunoglobulin in man. Lymphology 1978; 11: 138–42
- Schmekel B, Wollmer P, Venge P, Linden M, Blom-Bulow B. Transfer of 99mTc DTPA and bronchoalveolar lavage findings in patients with asymptomatic extrinsic allergic alveolitis. Thorax 1990; 45: 525–9
- Jensen H, Bro-Jorgensen K, Jarnum S, Olesen H, Yssing M. Transferrin metabolism in the nephrotic syndrome and in protein-losing gastroenteropathy. Scand J Clin Lab Invest 1968; 21: 293–304
- Schmidt PN, Blirup-Jensen S, Svendsen PJ, Wandall JH. Characterization and quantification of plasma proteins excreted in faeces from healthy humans. Scand J Clin Lab Invest 1995; 55: 35–45